Table 2.
Variables | Incidence of distant metastasis (%) | p value |
---|---|---|
Sex | 0.081 | |
Male | 27/573 (5.1) | |
Female | 9/354 (2.5) | |
Primary site | 0.003* | |
PIOC of the mandible | 4/16 (25.0) | |
Others | 32/871 (3.7) | |
Histological differentiation | < 0.001* | |
Well/Moderately | 26/824 (3.2) | |
Poorly | 10/63 (15.9) | |
Initial treatment for primary tumor | 0.202 | |
Surgery | 29/775 (3.7) | |
Brachytherapy | 7/112 (6.3) | |
pN | < 0.001* | |
No | 5/642 (0.8) | |
Yes | 31/245 (12.7) | |
Number of metastatic nodes | < 0.001* | |
0–3 | 18/821 (2.2) | |
≥ 4 | 18/66 (27.3) | |
Level of metastatic node | < 0.001* | |
No metastasis or I + II + III | 27/869 (3.1) | |
IV + V | 9/18 (50.0) | |
Contralateral node metastasis | < 0.001* | |
No | 27/850 (3.2) | |
Yes | 10/38 (26.3) | |
ENE | < 0.001* | |
No | 11/748 (1.5) | |
Yes | 25/139 (18.0) | |
Postoperative CT and/or RT | < 0.001* | |
No | 7/732 (1.0) | |
Yes | 29/155 (18.7) | |
Total | 36/887 (4.1) |
PIOC, primary intraosseous carcinoma; CT, chemotherapy; RT, radiotherapy; ENE, extranodal extension.
*Significant at p < 0.05.